nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer
|
Rijnders, Maud |
|
|
72 |
3 |
p. 759-767 |
artikel |
2 |
Blockade of IL-1α and IL-1β signaling by the anti-IL1RAP antibody nadunolimab (CAN04) mediates synergistic anti-tumor efficacy with chemotherapy
|
Rydberg Millrud, Camilla |
|
|
72 |
3 |
p. 667-678 |
artikel |
3 |
Compromised activity of natural killer cells in diffuse large b-cell lymphoma is related to lymphoma-induced modification of their surface receptor expression
|
Azoulay, Tehila |
|
|
72 |
3 |
p. 707-718 |
artikel |
4 |
Correction to: Identification of the molecular subtype and prognostic characteristics of pancreatic cancer based on CD8 + T cell-related genes
|
Xu, Dafeng |
|
|
72 |
3 |
p. 665 |
artikel |
5 |
Correction to: The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center study
|
Li, Chongwu |
|
|
72 |
3 |
p. 795 |
artikel |
6 |
Costimulatory molecule expression profile as a biomarker to predict prognosis and chemotherapy response for patients with small cell lung cancer
|
Wu, Peng |
|
|
72 |
3 |
p. 617-631 |
artikel |
7 |
Detecting monocyte trafficking in an animal model of glioblastoma using R2* and quantitative susceptibility mapping
|
Yang, Runze |
|
|
72 |
3 |
p. 733-742 |
artikel |
8 |
Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial
|
Adams, Alexandra M. |
|
|
72 |
3 |
p. 697-705 |
artikel |
9 |
Extracellular vesicles derived from M2-polarized tumor-associated macrophages promote immune escape in ovarian cancer through NEAT1/miR-101-3p/ZEB1/PD-L1 axis
|
Yin, Lili |
|
|
72 |
3 |
p. 743-758 |
artikel |
10 |
Identification of the molecular subtype and prognostic characteristics of pancreatic cancer based on CD8 + T cell-related genes
|
Xu, Dafeng |
|
|
72 |
3 |
p. 647-664 |
artikel |
11 |
Interplay between plasmacytoid dendritic cells and tumor-specific T cells in peripheral blood influences long-term survival in non-small cell lung carcinoma
|
Laheurte, Caroline |
|
|
72 |
3 |
p. 579-589 |
artikel |
12 |
Intratumoral pro-oxidants promote cancer immunotherapy by recruiting and reprogramming neutrophils to eliminate tumors
|
Ralph, Stephen John |
|
|
72 |
3 |
p. 527-542 |
artikel |
13 |
Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment
|
Stavrou, Victoria |
|
|
72 |
3 |
p. 543-560 |
artikel |
14 |
Machine learning algorithm-generated and multi-center validated melanoma prognostic signature with inspiration for treatment management
|
Liu, Zaoqu |
|
|
72 |
3 |
p. 599-615 |
artikel |
15 |
PD-L1 antibody enhanced β-glucan antitumor effects via blockade of the immune checkpoints in a melanoma model
|
Hu, Xin |
|
|
72 |
3 |
p. 719-731 |
artikel |
16 |
PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy
|
Li, Jun |
|
|
72 |
3 |
p. 633-645 |
artikel |
17 |
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma
|
Sonpavde, Guru P. |
|
|
72 |
3 |
p. 775-782 |
artikel |
18 |
Protein Expression of immune checkpoints STING and MHCII in small cell lung cancer
|
Dora, David |
|
|
72 |
3 |
p. 561-578 |
artikel |
19 |
Risk of pneumonitis in non-small cell lung cancer patients with preexisting interstitial lung diseases treated with immune checkpoint inhibitors: a nationwide retrospective cohort study
|
Sawa, Kenji |
|
|
72 |
3 |
p. 591-598 |
artikel |
20 |
Single-cell and spatial transcriptome analyses revealed cell heterogeneity and immune environment alternations in metastatic axillary lymph nodes in breast cancer
|
Mao, Xiaofan |
|
|
72 |
3 |
p. 679-695 |
artikel |
21 |
TCR extracellular domain genetically linked to CD28, 2B4/41BB and DAP10/CD3ζ -engineered NK cells mediates antitumor effects
|
Li, Shance |
|
|
72 |
3 |
p. 769-774 |
artikel |
22 |
The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center study
|
Li, Chongwu |
|
|
72 |
3 |
p. 783-794 |
artikel |